Locations:

Tag: peripheral artery disease (PAD)

alignment of crossing device in an endovascular procedure

October 21, 2024/Heart, Vascular and Thoracic/Vascular Surgery

Percutaneous Arterial Bypass for Long Fem-Pop Lesions: Uses Expand as Experience Mounts

Early learnings on use of the minimally invasive alternative to surgical bypass

illustration of femoropopliteal bypass with the DETOUR system

January 10, 2024/Heart, Vascular and Thoracic/Vascular Surgery

Pooled 2-Year Outcomes of DETOUR Trials Support Percutaneous Transfemoral Arterial Bypass

Larger data set confirms safety, efficacy and durability for SFA lesions over 20 cm

21-HVI-2541215 femoropopliteal-peripheral-artery-disease_650x450

February 1, 2022/Heart, Vascular and Thoracic/Vascular Surgery

Safety of Paclitaxel-Coated Balloon for PAD Confirmed Through Four Years of Follow-Up

Patient-level meta-analysis of ILLUMENATE trials finds no increased mortality with Stellarex DCB

20-HVI-1862825-CQD-Paclitaxel-coated-devices-for-PAD

June 24, 2020/Heart, Vascular and Thoracic/Research

Paclitaxel-Coated Devices for PAD: Mortality Signal Shrinks in Patient-Level Meta-Analysis

Risk attenuates as recovered data are added

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

February 21, 2018/Heart, Vascular and Thoracic/Insight & Perspectives

USPSTF Is Missing the Mark on the Ankle-Brachial Index in PAD Screening. Here’s Why.

Dr. Heather Gornik takes issue with new draft recommendation

BackPage 1 of 1Next